Biden’s “regulatory freeze” memorandum will likely impact several moves by the HHS in the final days and weeks of the Trump administration that impact the FDA, either by withdrawing or delaying the implementation of the actions.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,